Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for asthma
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on asthma or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on asthma and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Addressing therapeutic questions to help Canadian physicians optimize asthma management for their patients during the Covid-19 pandemic 1 ‘In Press’. Submitted for publication in the CJRCCSM on April 7, 2020. POSITION STATEMENT FROM THE CANADIAN THORACIC SOCIETY (CTS) ASTHMA ASSEMBLY STEERING COMMITTEE ADDRESSING THERAPEUTIC QUESTIONS TO HELP CANADIAN PHYSICIANS OPTIMIZE ASTHMA MANAGEMENT FOR THEIR PATIENTS DURING THE COVID-19 PANDEMIC Christopher Licskai a , Connie L. Yang b , Francine M (...) et de Pneumologie de Québec, Laval University, Québec, Québec, Canada; i Deparment of Medicine, Royal Victoria Regional Health Centre, Barrie, Ontario, Canada; j Department of Medicine, Queen’s University, Kingston, Ontario, Canada. Version 1.0 – April 7, 2020 This position statement aims to provide rapid guidance for Canadian physicians treating patients with asthma during the COVID-19 pandemic. The recommendations are informed by a very limited body of direct published data, inference from
Travel for people with allergy, asthma and anaphylaxis ASCIA Travel Plan: Anaphylaxis - Australasian Society of Clinical Immunology and Allergy (ASCIA) | | ASCIA Travel Plan: Anaphylaxis Other travel information for people at risk of anaphylaxis is available from Allergy & Anaphylaxis Australia: Page updated January 2019 Site last updated: 6 Nov 2019 Member Login Remember Me Log in ASCIA Update Information for the community about allergic diseases, immunodeficiencies and other immune diseases
Inhaled Salbutamol Shortage – Mitigation Strategy for Asthma CTS Guidance on Salbutamol Shortage – April 13,2020 1 Inhaled Salbutamol Shortage – Mitigation Strategy for Asthma April 13, 2020 Background 1) Health Canada and the pharmaceutical industry have identified that there was a three-fold increase in the demand for salbutamol inhalers in the first 3 weeks of March 2020. 2) This has resulted in a Tier 3 shortage, which by definition is “a situation when a manufacturer/importer is unable (...) and organizations projecting future need and purchasing product in advance of actual need [Stockpiling]. Mitigation Strategy Step 1 Provider communication to patients regarding asthma medication: If you have well controlled asthma, you should not need reliever medication. If you need reliever medication more than three times a week you should speak to your practitioner about ways to improve your asthma control. It is important that you are taking your regular maintenance controller medication as prescribed
Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents CHEST Guideline and Expert Panel Report AndreanneCôté,MD;RichardJ.Russell,MBBS;Louis-PhilippeBoulet,MD;PeterG.Gibson,DMed;KefangLai,MD,PhD; Richard S. Irwin, MD, Master FCCP; and Christopher E. Brightling, PhD; on behalf of the CHEST Expert Cough Panel * BACKGROUND: Asthma and non-asthmatic eosinophilic (...) and areas for future research. CHEST 2020; 158(1):68-96 KEYWORDS: asthma; bronchitis; cough ABBREVIATIONS: FENO= fractionalexhalednitric oxide;NAEB =non- asthmatic eosinophilic bronchitis; RCT = randomized controlled trial AFFILIATIONS: From the Centre de pneumologie (Drs Côté and Boulet), Québec Heart and Lung Institute, Laval University, Québec City, QC, Canada; Department of Respiratory Sciences (Drs Russell and Brightling), Institute for Lung Health, Glen?eld Hospital, Uni- versity of Leicester
The burden of exacerbations in mild asthma: a systematic review The burden of exacerbations in mild asthma: a systematic review | European Respiratory Society Main menu User menu Search Search for this keyword Search for this keyword The burden of exacerbations in mild asthma: a systematic review J. Mark FitzGerald , Peter J. Barnes , Bradley E. Chipps , Christine R. Jenkins , Paul M. O'Byrne , Ian D. Pavord , Helen K. Reddel ERJ Open Research 2020 6: 00359-2019; DOI: 10.1183/23120541.00359 (...) , St Joseph's Healthcare and Dept of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada Ian D. Pavord 6 Oxford Respiratory NIHR BRC, Nuffield Dept of Medicine, University of Oxford, Oxford, UK Helen K. Reddel 7 Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia Abstract Background Although most patients with asthma have mild disease, data on how mild asthma is defined, and how frequently exacerbations occur in this patient
, and adults with asthma have poorly controlled disease and experience bothersome symptoms, frequent and severe exacerbations, reduced lung function, and airway hyperresponsiveness [ , , , ]. After systematic assessment to optimize asthma care [ , ], including assessment of triggers, comorbidities and obstacles to asthma control, approximately 5–15% of the asthmatics remain to have severe asthma [ ], which is associated with an increased morbidity and mortality and possess a significant socioeconomic (...) and found favourable effects of omalizumab on the risk of exacerbations and reduction of ICS in severe allergic asthmatics [ ]. However, there is increasing understanding of the pivotal role of multi-dimensional, systematic assessment of patients presenting with uncontrolled asthma to correctly phenotype the patient as either difficult-to-treat or truly severe asthma [ , , ]. In fact, the majority of patients with uncontrolled asthma do not have severe asthma [ , ] and according to the Nordic consensus
/10.6061/clinics/2012(11)19 8. Mascarenhas JMO, Silva RCR, Assis AMO, Pinto EJ, Conceição JS, Barreto ML. Symptoms of asthma and associated factors in adolescents from Salvador, Bahia. Rev Bras Epidemiol. 2016;19(1):181-93. DOI: http://doi.org/10.1590/1980-5497201600010016 9. Robles-Ribeiro PG, Ribeiro M, Lianza S. Relationship between peak expiratory flow rare and shoulders posture in healthy individuals and moderate to severe asthmatic patients. J Asthma. 2005;42(9):783-6. DOI: http://doi.org/10.1080 (...) . Bruton A, Lewith GT. The Buteyko breathing technique for asthma: a review. Complement Ther Med. 2005;13(1):41-6. DOI: https://doi.org/10.1016/j.ctim.2005.01.003 23. Burgess J, Ekanayake B, Lowe A, Dunt D, Thien F, Dhamarge SC. Systematic review of the effectiveness of breathing retraining in asthma management. Expert Rev Respir Med. 2011;5(6):789-807. DOI: https://doi.org/10.1586/ers.11.69 24. McCaully HE. Breathing exercises as play for asthmatic children. Am J Matern Child Nurs. 1980;5(5):340-4. 25
Asthma and COVID-19 in Children - A Systematic Review and Call for Data Asthma and COVID-19 in children – a systematic review and call for data | medRxiv Search for this keyword Asthma and COVID-19 in children – a systematic review and call for data Jose A. Castro-Rodriguez , Erick Forno doi: https://doi.org/10.1101/2020.05.04.20090845 Jose A. Castro-Rodriguez 1 Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile For correspondence: Erick Forno (...) 2 Division of Pulmonary Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania, US ABSTRACT Rationale Whether asthma constitutes a risk factor for COVID-19 is unclear. Methods We performed a systematic literature search in three stages: First, we reviewed PubMed, EMBASE and CINAHL for systematic reviews of SARS-CoC-2 and COVID-19 in pediatric populations, and reviewed their primary articles; next, we searched PubMed for studies on COVID-19
Characteristics of Existing Asthma Self-Management Education Packages Characteristics of Existing Asthma Self-Management Education Packages Technical Brief Number 35 RTechnical Brief Number 35 Characteristics of Existing Asthma Self-Management Education Packages Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00005-I Prepared by: ECRI Institute – Penn Medicine Evidence (...) -based Practice Center Philadelphia, PA Investigators: Brian F. Leas, M.S., M.A. Kelley Tipton, M.P.H. Tyra Bryant-Stephens, M.D. Michelle Jackson-Ware, R.N., B.S.N. Nikhil Mull, M.D. Amy Y. Tsou, M.D., M.Sc. AHRQ Publication No. 20-EHC008 April 2020 ii Key Messages Purpose To identify the components that comprise asthma self-management education (AS-ME) packages used in the United States, and examine, compare, and organize their key characteristics and available research to enable a better
adverse events was of low quality, with very few events (10 total) reported overall. Mortality was not reported in any of the studies. There was low statistical heterogeneity between the studies for each of the outcomes reported ( I 2 =0). Commentary Asthma is a chronic respiratory condition that results in constriction of the airways because of inflammation and excess mucus production. Asthmatic patients typically have wheezing caused by narrowed airways, and symptoms are usually controlled (...) Do Antibiotics Improve Outcomes in Patients With Acute Asthma Exacerbations? Do Antibiotics Improve Outcomes in Patients With Acute Asthma Exacerbations? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 74, Issue 5, Pages 711–712 Do Antibiotics Improve Outcomes in Patients With Acute Asthma Exacerbations? x Latha Ganti , MD, MBA (EBEM Commentator) , x Javier Rosario , MD (EBEM Commentator) Department
Advice for Healthcare Professionals Treating People with Asthma (adults) in relation to COVID-19 1 Version 4.0 7/4/20 Advice for Healthcare Professionals Treating People with Asthma (adults) in relation to COVID-19 What can I suggest my patients do to keep themselves healthy? For people with asthma, the best way of staying healthy and recovering if infected with COVID-19 is to ensure their asthma is as stable as possible. This means taking inhaled steroids and other routine medications (...) regularly, as prescribed and detailed in their personal asthma action plan. Having a reliever inhaler is also important if asthma worsens. Ensuring people have had their inhaler technique checked recently is important and you can share this website: https://www.asthma.org.uk/advice/inhaler-videos/ Advise patients to ensure they have a sufficient supply of their medication at home and order them in plenty of time to ensure they do not run out. Emphasise that they do not need to over order/ stock up